Related Experiment Video

Updated: Aug 23, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

304

The Impact of Dietary Intervention in Obese Children on Asthma Prevention and Control

Hanna Sikorska-Szaflik1, Joanna Połomska1, Barbara Sozańska1

  • 11st Department and Clinic of Paediatrics, Allergology and Cardiology Wrocław Medical University, ul. Chałubińskiego 2-2a, 50-368 Wrocław, Poland.

Nutrients
|October 27, 2022
PubMed

Insights

Pediatric asthma and obesity are rising. Dietary intervention and weight loss in obese children may improve asthma control and quality of life, suggesting a link between weight management and respiratory health.

Area of Science:

  • Pediatric Pulmonology
  • Pediatric Endocrinology
  • Nutritional Science

Background:

  • Increasing prevalence of pediatric asthma and obesity, with emerging obese-asthma phenotypes.
  • Obese children with asthma exhibit more severe symptoms, frequent exacerbations, poorer treatment response, and reduced quality of life.
  • Potential overlapping genetic and immunologic origins for asthma and obesity.

Purpose of the Study:

  • To analyze the impact of dietary intervention and weight loss in obese children.
  • To evaluate the effects on asthma prevention and control in this population.

Main Methods:

  • Review of current literature on the interplay between obesity, diet, and asthma in children.
  • Analysis of studies focusing on weight management strategies for obese children with asthma.

Main Results:

  • Dietary intervention and weight loss are compelling modifiable factors for managing pediatric obesity and asthma.
  • Evidence suggests a multifactorial relationship, with potential benefits for asthma control and quality of life through weight management.

Conclusions:

  • Weight loss and dietary changes in obese children show promise for improving asthma outcomes.
  • Further research into the shared etiologies and therapeutic interventions for pediatric obesity and asthma is warranted.

Keywords:
allergyasthmaobesityprevention

More Related Videos

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.2K
Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.2K

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
523
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
403
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
414
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K